Literature DB >> 7826947

Human Fas ligand: gene structure, chromosomal location and species specificity.

T Takahashi1, M Tanaka, J Inazawa, T Abe, T Suda, S Nagata.   

Abstract

Fas ligand (FasL) is a 40 kDa type II membrane protein belonging to the tumor necrosis factor family, which induces apoptosis by binding to its receptor, Fas. In this report, we isolated the chromosomal gene for human FasL. The human FasL gene consists of approximately 8.0 kb and is split into four exons. The human FasL gene was mapped on chromosome 1q23 by in situ hybridization against human metaphase chromosomes. Human FasL cDNA was isolated by the reverse polymerase chain reaction of mRNA prepared from human activated peripheral blood lymphocytes. Human FasL is a type II membrane protein consisting of 281 amino acids with a calculated M(r) of 31,759. It has an identity of 76.9% at the amino acid sequence level with mouse FasL. Both human and mouse recombinant FasL expressed in COS induced apoptosis in the cells expressing either human Fas or mouse Fas, indicating that FasL fully cross-reacts between human and mouse. A comparison of human and mouse FasL chromosomal genes indicated that a approximately 300 bp sequence upstream of the ATG initiation codon is highly conserved between them. Several transcription cis-regulatory elements such as SP-1, NF-kappa B and IRF-1 were recognized in this region.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7826947     DOI: 10.1093/intimm/6.10.1567

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  87 in total

1.  Induction of apoptosis by double-stranded-RNA-dependent protein kinase (PKR) involves the alpha subunit of eukaryotic translation initiation factor 2 and NF-kappaB.

Authors:  J Gil; J Alcamí; M Esteban
Journal:  Mol Cell Biol       Date:  1999-07       Impact factor: 4.272

2.  Expression of perforin and Fas ligand mRNA in the liver of viral hepatitis.

Authors:  M Tagashira; K Yamamoto; K Fujio; T Nagano; R Okamoto; N Ibuki; K Yabushita; S Matsumura; N Okano; T Tsuji
Journal:  J Clin Immunol       Date:  2000-09       Impact factor: 8.317

3.  Fas and FasL expression in the spinal cord following cord hemisection in the monkey.

Authors:  Liu Jia; Zou Yu; Li Hui; Guan Yu-Guang; Zhou Xin-Fu; You Chao; Xiyang Yanbin; Zhan Xi; Wang Jun; Heng Xin-Hua; Hen Xin-Hua; Wang Ting-Hua
Journal:  Neurochem Res       Date:  2010-12-23       Impact factor: 3.996

4.  Intraepithelial lymphocytes in normal human intestine do not express proteins associated with cytolytic function.

Authors:  A Chott; D Gerdes; A Spooner; I Mosberger; J A Kummer; E C Ebert; R S Blumberg; S P Balk
Journal:  Am J Pathol       Date:  1997-08       Impact factor: 4.307

5.  Reovirus-induced apoptosis requires activation of transcription factor NF-kappaB.

Authors:  J L Connolly; S E Rodgers; P Clarke; D W Ballard; L D Kerr; K L Tyler; T S Dermody
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

6.  TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL.

Authors:  H Walczak; M A Degli-Esposti; R S Johnson; P J Smolak; J Y Waugh; N Boiani; M S Timour; M J Gerhart; K A Schooley; C A Smith; R G Goodwin; C T Rauch
Journal:  EMBO J       Date:  1997-09-01       Impact factor: 11.598

Review 7.  CD95 (Fas/APO-1)/CD95L in the gastrointestinal tract: fictions and facts.

Authors:  J Sträter; P Möller
Journal:  Virchows Arch       Date:  2003-02-11       Impact factor: 4.064

8.  Molecular basis of rifampicin-induced inhibition of anti-CD95-induced apoptosis of peripheral blood T lymphocytes: the role of CD95 ligand and FLIPs.

Authors:  Sastry Gollapudi; Suman Jaidka; Sudhir Gupta
Journal:  J Clin Immunol       Date:  2003-01       Impact factor: 8.317

9.  Fas ligand-induced murine pulmonary inflammation is reduced by a stable decoy receptor 3 analogue.

Authors:  Mark A Wortinger; Joseph W Foley; Patrick Larocque; Derrick R Witcher; Michael Lahn; Joseph A Jakubowski; Andrew Glasebrook; Ho Yeong Song
Journal:  Immunology       Date:  2003-10       Impact factor: 7.397

10.  Enhancement of the proapoptotic properties of newcastle disease virus promotes tumor remission in syngeneic murine cancer models.

Authors:  Sara Cuadrado-Castano; Juan Ayllon; Mena Mansour; Janis de la Iglesia-Vicente; Stefan Jordan; Shashank Tripathi; Adolfo García-Sastre; Enrique Villar
Journal:  Mol Cancer Ther       Date:  2015-03-11       Impact factor: 6.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.